Navigation Links
Study finds increased 'sibling risk' of obstructive sleep apnea in children
Date:7/31/2009

unaffected siblings.

The study also examined the sibling risk of adenotonsillar hypertrophy, an important risk factor for pediatric OSA. A total of 13,656 boys and 11,648 girls had a first hospital diagnosis of hypertrophy of the tonsils, or hypertrophy of the adenoids and tonsils. The overall standardized incidence ratios for adenotonsillar hypertrophy among those who had at least one affected sibling were 4.53 for boys and 4.94 for girls. Although this familial risk was much lower than in the group with OSA, the authors report that the increase was highly significant and the numbers of children were much larger than in the OSA group.

The American Academy of Sleep Medicine reports that the prevalence of OSA is approximately two percent in otherwise healthy young children. OSA occurs when soft tissue in the back of the throat collapses and blocks the airway during sleep. Most children with OSA have a history of snoring that tends to be loud and may include obvious pauses in breathing and gasps for breath. Parents often notice that the child seems to be working hard to breathe during sleep.

According to the authors, the increased risks for both OSA and adenotonsillar hypertrophy could be an expression of genetic or shared environmental mechanisms. Recent genetic studies of both adult and pediatric patients with OSA indicate that genetic mechanisms do play an important role. Possible environmental factors include the increased medical awareness of sleep disordered breathing over time, both among parents and doctors.

The authors recommend that medical providers ask about sleep-related symptoms in siblings when children present with clinical signs or symptoms of OSA.


'/>"/>

Contact: Kelly Wagner
kwagner@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Study Measures Benefits of More Involved Fathers
2. Thousands of Nebraskans Could Lose Private Insurance, Study Shows
3. Thousands of New Mexicans Could Lose Private Insurance, Study Shows
4. Millions of Pennsylvanians Could Lose Private Insurance, Study Shows
5. Millions of Virginians Could Lose Private Insurance, Study Shows
6. Thousands of Montanans Could Lose Private Insurance, Study Shows
7. Study Shows Divorced, Widowed Adults Have Increased Health Risks
8. Summer heat increases risk of amniotic fluid level deficiency, Ben-Gurion University study reveals
9. Study Finds Weight-Loss Surgery Safer Than Thought
10. New Study Identifies Strategies to Retain Experienced Nurses as Nursing Shortage Looms & Nations Health Care Needs Grow
11. Thousands of Maine Residents Could Lose Private Insurance, Study Shows

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...in younger women may up chances of disease, study ...s) -- Mammograms may actually boost the risk of br...uggests. , Dutch researchers analyzed six previ... of low-dose radiation exposure from mammography a...st cancer risk and two looking at the effect of ra...
(Date:12/1/2009)... Pilots will enable local organizations to te...r for consumers who lack access , ...en Fund, a nonprofit venture firm addressing pover...t has selected four organizations in Kenya to cond... transportation and storage. , , ,The pilot progra...
(Date:12/1/2009)..., IRVINE, Calif., Dec. 1 ...CO-Oximetry(TM) and Measure-Through Motion and Low...arance of its latest innovation -- Masimo Rainbow ...sive and continuous respiration rate (RRa(TM)) tha...ompliance. Masimo Rainbow SET Acoustic Monitoring...
(Date:12/1/2009)... Free hearing aids will be given by Estes Aud... Austin, TX (PRWEB) December...m ), a professional hearing healthcare provider de...ired and their families, announced today the begin...giveaway. Each year, Estes Audiology donates two ...
(Date:12/1/2009)... All Federal and Georgia State Retirees who a.... This new benefit is part of the Medicare Advanta...fee for service (PFFS) Options offered by CIGNA, B...r Permanente. Atlanta Hearing Associates has three... Oconee / Greensboro, GA and Lake Sinclair / Mille...
Breaking Medicine News(10 mins):Health News:Mammograms May Boost Cancer Risk in High-Risk Women 2Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 2Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 3Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 2Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 3Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 5Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 6Health News:Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 2Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 2Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 3Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 4
...to offer good news for older adults .The first stu... depression // in the elderly. Researchers studied...participants suffered from major depression, while...study show seniors who received the home-based pro...
...ng pneumonia may mean just a short-term lease on a...lts of the study show // increasing age combined w...e, an altered mental state, and anemia were signif...olled diabetes and a hematocrit (ratio of the volu...
...tion after heart surgery may not be the be the wis...archers.// A recent study confirms that corona...heart medications, such as beta blockers and ACE i...edication. However, this assumption was questioned...
...e conditions such as chronic bronchitis and emphys... // and gradual loss of lung function that cannot ...use of death in the United States. A test known...pirometry test and a screening questionnaire to de...
...tendon near a joint becomes inflamed. Treatment is... a new approach relieves the pain of this common c... with tendonitis are finding relief with extracorp...ave treatments to relieve the pain of chronic tend...
...dy researchers say zinc supplements may increase t...ttention deficit hyperactivity // disorder ( ADHD ...n of melatonin, which helps regulate dopamine func... of reward and pleasure. Zinc is a mineral tha...
Other Medicine News:
(Date:11/30/2009)...C., Nov. 30 Microban International...l product protection, is pleased to announce their... Corp., the largest U.S. manufacturer and distribu...orp is launching two new lines of ceramic tile wit...;) patent pending silver based technology, in orde...
(Date:11/30/2009)...PRNewswire/ -- Breast-Specific Gamma Imaging (BSGI... technique for the detection of ductal carcinoma i...er. BSGI is a molecular breast imaging technique t...and discover very early stage cancers. According t...f the Radiological Society of North America (RSNA)...
(Date:11/30/2009)..., Nov. 30 SCOLR Pharma, ...vember 25, 2009, the NYSE Amex LLC (the "Exchange"...mpany,s plan to comply with its previously disclos... the Exchange Company Guide. Specifically, the de...losses which were so substantial in relation to it...
Breaking Medicine Technology:Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4University of Louisville neuroscientists hope to get people walking again 58667 1Experts gather at McGill University to address food security challenges 10216 1EPA reviews Univ of Michigan dioxin study 10212 1EPA reviews Univ of Michigan dioxin study 10212 2
... EnVivo Pharmaceuticals, Inc.,a privately held bio...egenerative diseases, today announced progress on ...chizophrenia and Huntington,s,diseases. EnVivo Ph...orally,active Alpha 7 Nicotinic Acetylcholine Rece...ts associated with Alzheimer,s disease and,Schizop...
...h Joint Venture Between Bristol-Myers Squibb, Co...n HIV Treatment -, PRINCETON, N.J. and FOSTER CIT...ol-Myers Squibb Company (NYSE: BMY ) and Gilead S...t Health Canada has approved ATRIPLA(R),(efavirenz...fumarate 300,mg) for the treatment of HIV-1 infect...
Other Medicine Technology:EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimer's, Schizophrenia and Huntington's Diseases 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9
.../See™ is a 1-step, hand-held, point-of-care ...ug metabolites in human urine. The TOX/See device... drugs in 3 to 8 minutes and requires only a few d...ly packaged to maximize convenience and ease of us...
ESR-10 Manual Rack
...eck Cytometry Concentrate is for use as a sheath f...ach 70ml bottle of Cytometry Concentrate dilutes t...d to Cubitainers, Streck Cytometry Concentrate red...es money without compromising performance. Streck ...
CD-Chex CD34 Leukocyte Control
Medicine Products: